A unique presentation of Graves’ disease in a pregnant woman with severe hypothyroidism

References

• Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol. 2011;54(3):478–487.
   PubMed Web of Science ®Google Scholar
• Moreno-Reyes R, Glinoer D, Van Oyen H, et al. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab. 2013;98(9):3694–3701.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):238–249.
   PubMed Web of Science ®Google Scholar
• Kahaly GJ, Diana T, Olivo PD. Tsh receptor antibodies: relevance & utility. Endocr Pract. 2020;26(1):97–106.
   PubMed Web of Science ®Google Scholar
• McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 2013;23(1):14–24.
   PubMed Web of Science ®Google Scholar
• Bucci I, Giuliani C, Napolitano G. Thyroid-Stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne). 2017;8:137.
   PubMed Web of Science ®Google Scholar
• Feingold SB, Smith J, Houtz J, et al. Prevalence and functional significance of thyrotropin receptor blocking antibodies in children and adolescents with chronic lymphocytic thyroiditis. J Clin Endocrinol Metab. 2009;94(12):4742–4748.
   PubMed Web of Science ®Google Scholar
• Diana T, Krause J, Olivo PD, et al. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Clin Exp Immunol. 2017;189(3):304–309.
   PubMed Web of Science ®Google Scholar
• Takasu N, Yamada T, Sato A, et al. Graves' disease following hypothyroidism due to hashimoto's disease: studies of eight cases. Clin Endocrinol (Oxf). 1990;33(6):687–698.
   PubMed Web of Science ®Google Scholar
• Kraiem Z, Baron E, Kahana L, et al. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf). 1992;36(2):211–214.
   PubMed Web of Science ®Google Scholar
• Takasu N, Matsushita M. Changes of TSH-Stimulation blocking antibody (TSBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive graves' patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients. J Thyroid Res. 2012;2012:182176.
   PubMedGoogle Scholar
• Rotondi M, Virili C, Pinto S, et al. The clinical phenotype of graves' disease occurring as an isolated condition or in association with other autoimmune diseases. J Endocrinol Invest. 2020;43(2):157–162.
   PubMed Web of Science ®Google Scholar
• Kung AW, Jones BM. A change from stimulatory to blocking antibody activity in graves' disease during pregnancy. J Clin Endocrinol Metab. 1998;83(2):514–518.
   PubMed Web of Science ®Google Scholar
• Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315–389.
   PubMed Web of Science ®Google Scholar
• Lee SY, Pearce EN. Testing, monitoring, and treatment of thyroid dysfunction in pregnancy. J Clin Endocrinol Metab. 2021;106(3):883–892.
   PubMed Web of Science ®Google Scholar
• Glinoer D, Abalovich M. Unresolved questions in managing hypothyroidism during pregnancy. BMJ. 2007;335(7614):300–302.
   PubMedGoogle Scholar
• Li SW, Chan SY. Management of overt hypothyroidism during pregnancy. Best Pract Res Clin Endocrinol Metab. 2020;34(4):101439.
   PubMed Web of Science ®Google Scholar
• Abeillon-du Payrat J, Chikh K, Bossard N, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol. 2014;171(4):451–460.
   PubMed Web of Science ®Google Scholar
• Banigé M, Estellat C, Biran V, et al. Study of the factors leading to fetal and neonatal dysthyroidism in children of patients with Graves disease. J Endocr Soc. 2017;1(6):751–761.
   PubMed Web of Science ®Google Scholar
• van Dijk MM, Smits IH, Fliers E, et al. Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review. Thyroid. 2018;28(2):257–264.
   PubMed Web of Science ®Google Scholar
• Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab. 1997;82(9):3099–3102.
   PubMed Web of Science ®Google Scholar
• Donnelly MA, Wood C, Casey B, et al. Early severe fetal Graves disease in a mother after thyroid ablation and thyroidectomy. Obstet Gynecol. 2015;125(5):1059–1062.
   PubMed Web of Science ®Google Scholar
• Balucan FS, Morshed SA, Davies TF. Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance. J Thyroid Res. 2013;2013:182472.
   PubMedGoogle Scholar
• Rose SR, Brown RS, Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;17(6):2290–2303.
   Google Scholar
• Munoz JL. Fetal thyroid disorders: pathophysiology, diagnosis and therapeutic approaches. J Gynecol Obstet Hum Reprod. 2019;48(4):231–233.
   PubMed Web of Science ®Google Scholar
• Uenaka M, Tanimura K, Tairaku S, et al. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease. Eur J Obstet Gynecol Reprod Biol. 2014;177:89–93.
   PubMed Web of Science ®Google Scholar
• Brown RS, Bellisario RL, Botero D, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab. 1996;81(3):1147–1151.
   PubMed Web of Science ®Google Scholar